Non-peptide oxytocin receptor ligands and hamster circadian wheel running rhythms

Brain Research

Volumn 1585, Issue , 2014, Pages 184-190

  Gannon, Robert L ^a  

^a VALDOSTA STATE UNIVERSITY   (United States)

Author keywords

Anxiety; Autism; Biological rhythms; Depression; Schizophrenia

Indexed keywords

HORMONE RECEPTOR BLOCKING AGENT; HORMONE RECEPTOR STIMULATING AGENT; OXYTOCIN RECEPTOR; UNCLASSIFIED DRUG; WAY 162720; WAY 267464; 4-(3,5-DIHYDROXYBENZYL)-N-(2-METHYL-4-((1-METHYL-4,10-DIHYDROPYRAZOLO(3,4-B)(1,5)BENZODIAZEPIN-5(1H)-YL)CARBONYL)BENZYL)PIPERAZINE-1-CARBOXAMIDE; BENZODIAZEPINE DERIVATIVE; LIGAND; PYRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; LIGHT DARK CYCLE; MALE; NONHUMAN; SYRIAN HAMSTER; AGONISTS; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; MESOCRICETUS; MOTOR ACTIVITY; PHOTOSTIMULATION; PHYSIOLOGY;

CRICETINAE;

ANIMALS; BENZODIAZEPINES; CIRCADIAN RHYTHM; LIGANDS; MALE; MESOCRICETUS; MOTOR ACTIVITY; PHOTIC STIMULATION; PYRAZOLES; RECEPTORS, OXYTOCIN;

EID: 84907705254     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2014.08.034     Document Type: Article

References (33)

1. H.E. Albers, and M. Bamshad Role of vasopressin and oxytocin in the control of social behavior in Syrian hamsters (Mesocricetus auratus) Prog. Brain Res. 119 1998 395 408
2. H.E. Albers, C.F. Ferris, S.E. Leeman, and B.D. Goldman Avian pancreatic polypeptide phase shifts hamster circadian rhythms when microinjected into the suprachiasmatic region Science 223 1984 833 835
3. K. Devarajan, E.G. Marchant, and B. Rusak Circadian and light regulation of oxytocin and parvalbumin protein levels in the ciliated ependymal layer of the third ventricle in the C57 mouse Neuroscience 134 2005 539 547
4. K. Devarajan, and B. Rusak Oxytocin levels in the plasma and cerebrospinal fluid of male rats: effects of circadian phase, light and stress Neurosci. Lett. 367 2004 144 147
5. Z. Dzirbikova, A. Kiss, M. Okuliarova, L. Kopkan, and L. Cervenka Expression of per1 clock gene and genes of signaling peptides vasopressin, vasoactive intestinal peptide, and oxytocin in the suprachiasmatic and paraventricular nuclei of hypertensive TGR[mREN2]27 rats Cell. Mol. Neurobiol. 31 2011 225 232
6. A. Ermisch, T. Barth, H.J. Ruhle, J. Skopkova, P. Hrbas, and R. Landgraf On the blood-brain barrier to peptides: accumulation of labeled vasopressin, DesGlyNH2-vasopressin and oxytocin by brain regions Endocrinol. Exp. 19 1985 29 37
7. G. Glickman Circadian rhythms and sleep in children with autism Neurosci. Biobehav. Rev. 34 2010 755 768
8. Y.F. Guzman, N.C. Tronson, K. Sato, I. Mesic, A.L. Guedea, K. Nishimori, and J. Radulovic Role of oxytocin receptors in modulation of fear by social memory Psychopharmacology 231 2014 2097 2105
9. I.B. Hickie, S.L. Naismith, R. Robillard, E.M. Scott, and D.F. Hermens Manipulating the sleep-wake cycle and circadian rhythms to improve clinical management of major depression BMC Med. 11 2013 79
10. E. Hollander, J. Bartz, W. Chaplin, A. Phillips, J. Sumner, L. Soorya, E. Anagnostou, and S. Wasserman Oxytocin increases retention of social cognition in autism Biol. Psychiatry 61 2007 498 503
11. Kim S., Soeken T.A., Cromer S.J., Martinez S.R., Hardy L.R. and Strathearn L., Oxytocin and postpartum depression: delivering on what's known and what's not, Brain Res., 10.1016/j.brainres.2013.11.009 (in press)
12. K.E. Krout, J. Kawano, T.C. Mettenleiter, and A.D. Loewy CNS inputs to the suprachiasmatic nucleus of the rat Neuroscience 110 2002 73 92
13. F. Levi, and U. Schibler Circadian rhythms: mechanisms and therapeutic implications Annu. Rev. Pharmacol. Toxicol. 47 2006 593 628
14. A.C. Liu, W.G. Lewis, and S.A. Kay Mammalian circadian signaling networks and therapeutic targets Nat. Chem. Biol. 3 2007 631 640
15. K. MacDonald, and D. Feifel Oxytocin in schizophrenia: a review of evidence for its therapeutic effects Acta Neuropsychiatr. 24 2012 130 146
16. K. MacDonald, and D. Feifel Helping oxytocin deliver: considerations in the development of oxytocin-based therapeutics for brain disorders Front. Neurosci. 7 2013 35
17. M. Manning, A. Misicka, A. Olma, K. Bankowski, S. Stoev, B. Chini, T. Durroux, B. Mouillac, M. Corbani, and G. Guillon Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics J. Neuroendocrinol. 24 2012 609 628
18. 8]vasotocin on the firing rate of suprachiasmatic neurons in vitro Neuroscience 62 1994 783 792
19. L.P. Morin Neuroanatomy of the extended circadian rhythm system Exp. Neurol. 243 2013 4 20
20. L.P. Morin, and J. Blanchard Organization of the hamster paraventricular hypothalamic nucleus J. Comp. Neurol. 332 1993 341 357
21. R.J. Ni, Y.M. Shu, J. Wang, J.C. Yin, L. Xu, and J.N. Zhou Distribution of vasopressin, oxytocin and vasoactive intestinal polypeptide in the hypothalamus and extrahypothalamic regions of tree shrews Neuroscience 265 2014 124 136
22. T. Partonen Clock gene variants in mood and anxiety disorders J. Neural Transm. 119 2012 1133 1145
23. M.R. Ralph, R.G. Foster, F.C. Davis, and M. Menaker Transplanted suprachiasmatic nucleus determines circadian period Science 247 1990 975 978
24. R.H. Ring, J.E. Malberg, L. Potestio, J. Ping, S. Boikess, B. Luo, L.E. Schechter, S. Rizzo, Z. Rahman, and S. Rosenzweig-Lipson Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications Psychopharmacology 185 2006 218 225
25. R.H. Ring, L.E. Schechter, S.K. Leonard, J.M. Dwyer, B.J. Platt, R. Graf, S. Grauer, C. Pulicicchio, L. Resnick, Z. Rahman, S.J. Sukoff Rizzo, B. Luo, C.E. Beyer, S.F. Logue, K.L. Marquis, Z.A. Hughes, and S. Rosenzweig-Lipson Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist Neuropharmacology 58 2010 69 77
26. S. Tordjman, I. Najjar, E. Bellissant, G.M. Anderson, M. Barburoth, D. Cohen, N. Jaafari, O. Schischmanoff, R. Fagard, E. Lagdas, S. Kermarrec, S. Ribardiere, M. Botbol, C. Fougerou, G. Bronsard, and J. Vernay-Leconte Advances in the research of melatonin in autism spectrum disorders Int. J. Mol. Sci. 14 2013 20508 20542
27. C. Vaccari, S.J. Lolait, and N.L. Ostrowski Comparative distribution of vasopressin V1b and oxytocin receptor messenger ribonucleic acids in brain Endocrinology 139 1998 5015 5033
28. E.A. Van der Zee, M. Oklejewicz, K. Jansen, S. Daan, and M.P. Gerkema Vasopressin immunoreactivity and release in the suprachiasmatic nucleus of wild-type and tau mutant Syrian hamsters Brain Res. 936 2002 38 46
29. N. Vrang, P.J. Larsen, M. Moller, and J.D. Mikkelsen Topographical organization of the rat suprachiasmatic-paraventricular projection J. Comp. Neurol. 353 1995 585 603
30. D.C. Whitman, and H.E. Albers Oxytocin immunoreactivity in the hypothalamus of female hamsters Cell Tissue Res. 291 1998 231 237
31. Y.-H. Wu, J.-N. Zhou, R. Balesar, U. Unmehopa, A. Bao, R. Josckers, J. Van Heerikhuize, and D.F. Swaab Distribution of MT1 melatonin receptor immunoreactivity in the human hypothalamus and pituitary gland: colocalization of MT1 with vasopressin, oxytocin, and corticotropin-releasing hormone J. Comp. Neurol. 499 2006 897 910
32. Y. Yamaguchi, T. Suzuki, Y. Mizoro, H. Kori, K. Okada, Y. Chen, J.-M. Fustin, F. Yamazaki, N. Mizuguchi, J. Zhang, X. Dong, G. Tsujimoto, Y. Okuno, M. Doi, and H. Okamura Mice genetically deficient in vasopressin V1a and V1b receptors are resistant to jet lag Science 342 2013 85 90
33. L.J. Young, S. Muns, Z. Wang, and T.R. Insel Changes in oxytocin receptor mRNA in rat brain during pregnancy and the effects of estrogen and interleukin-6 J. Neuroendocrinol. 9 1997 859 865